Literature DB >> 19131573

MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain.

Erno Vreugdenhil1, Carla S L Verissimo, Rob Mariman, Jessica T Kamphorst, Joana S Barbosa, Thijs Zweers, Danielle L Champagne, Theo Schouten, Onno C Meijer, E Ron de Kloet, Carlos P Fitzsimons.   

Abstract

Glucocorticoids (GCs) exert profound effects on a variety of physiological processes, including adaptation to stress, metabolism, immunity, and neuronal development. Cellular responsiveness to GCs depends on numerous factors, including the amount of the glucocorticoid receptor (GR) protein. We tested the hypothesis that micro-RNAs (miRs), a recently discovered group of noncoding RNAs involved in mRNA translation, might control GR activity by reducing GR protein levels in neuronal tissues. We tested a panel of five miRs consisting of 124aa, 328, 524, 22, and 18. We found that miRs 18 and 124a reduced GR-mediated events in addition to decreasing GR protein levels. miR reporter assays revealed binding of miR-124a to the 3' untranslated region of GR. In correspondence, the activation of the GR-responsive gene glucocorticoid-induced leucine zipper was strongly impaired by miR-124a and -18 overexpression. Although miR-18 is expressed widely throughout the body, expression of miR-124a is restricted to the brain. Endogenous miR-124a up-regulation during neuronal differentiation of P19 cells was associated with a decreasing amount of GR protein levels and reduced activity of luciferase reporter constructs bearing GR 3' untranslated regions. Furthermore, we show that miR-124a expression varies over time during the stress hyporesponsive period, a neonatal period when GC signaling is modulated. Our findings demonstrate a potential role for miRs in the regulation of cell type-specific responsiveness to GCs, as may occur during critical periods of neuronal development. Ultimately, our results may provide a better understanding of the etiology of stress-related diseases as well as the efficacy of GC therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131573     DOI: 10.1210/en.2008-1335

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  92 in total

Review 1.  Evidence demonstrating role of microRNAs in the etiopathology of major depression.

Authors:  Yogesh Dwivedi
Journal:  J Chem Neuroanat       Date:  2011-04-14       Impact factor: 3.052

2.  Meeting report: nuclear receptors: transcription factors and drug targets connecting basic research with translational medicine.

Authors:  Jan Tuckermann; William Bourguet; Susanne Mandrup
Journal:  Mol Endocrinol       Date:  2010-06-02

Review 3.  MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases.

Authors:  Sara De Iudicibus; Marianna Lucafò; Stefano Martelossi; Chiara Pierobon; Alessandro Ventura; Giuliana Decorti
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

Review 4.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

5.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

Review 6.  The involvement of microRNAs in major depression, suicidal behavior, and related disorders: a focus on miR-185 and miR-491-3p.

Authors:  Gianluca Serafini; Maurizio Pompili; Katelin F Hansen; Karl Obrietan; Yogesh Dwivedi; Noam Shomron; Paolo Girardi
Journal:  Cell Mol Neurobiol       Date:  2013-11-09       Impact factor: 5.046

7.  Prenatal arsenic exposure alters REST/NRSF and microRNA regulators of embryonic neural stem cell fate in a sex-dependent manner.

Authors:  Christina R Tyler; Matthew T Labrecque; Elizabeth R Solomon; Xun Guo; Andrea M Allan
Journal:  Neurotoxicol Teratol       Date:  2016-10-14       Impact factor: 3.763

8.  Identification of MicroRNA-124-3p as a Putative Epigenetic Signature of Major Depressive Disorder.

Authors:  Bhaskar Roy; Michael Dunbar; Richard C Shelton; Yogesh Dwivedi
Journal:  Neuropsychopharmacology       Date:  2016-08-31       Impact factor: 7.853

Review 9.  MicroRNAs in depression and suicide: Recent insights and future perspectives.

Authors:  Yogesh Dwivedi
Journal:  J Affect Disord       Date:  2018-07-24       Impact factor: 4.839

10.  MicroRNA Regulatory Networks Provide Feedback Mechanisms for Steroid Receptor Signaling.

Authors:  Qun Zhou; Gabriel Eades
Journal:  J Steroids Horm Sci       Date:  2012-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.